APEX Press Releases


Jim Rogers CEO

APEX Biologix Enters Into Know-How License Agreement with Mayo Clinic for Development of Regenerative Medicine Products

SALT LAKE CITY APEX Biologix, a leading regenerative medicine device company that specializes in the development of advanced patient therapies, announced today it has entered into a know-how license agreement with Mayo Clinic to jointly develop new regenerative medicine products.

Jim Rogers CEO

APEX Biologix Appoints Jim Rogers as New Chief Executive Officer

APEX Biologix, a leader in the regenerative medicine industry, announced today the addition of a new visionary executive to the company. Jim Rogers brings more than 20 years of creation and business development in the medical device industry to the growing team at APEX Biologix.

XCELL Protein Concentrator System

APEX Biologix Announces New, Industry-Leading XCELL Protein Concentrator System

The new XCELL PC filter is more efficient, achieves greater concentrations, simplifies processing.

Xcell BMC Bone Marrow

APEX Biologix Launches its Newly Reconfigured Bone Marrow System for Regenerative Medicine Procedures

XCELL BMC to Provide System Features Specifically Designed for Surgery Settings in Hospitals, Clinics, and Surgical Centers

MedTech Accelerator Program 2022 link

APEX Biologix Chosen to Participate in the Mayo Clinic - Arizona State University MedTech Accelerator Program

APEX is one of eight companies selected internationally as part of distinguished group.

APEX Biologix Announces Sean Woodward as New Marketing Manager to our Salt Lake City Team

APEX Biologix Announces Sean Woodward as New Marketing Manager to our Salt Lake City Team

Murray, UT. December 15th, 2021. APEX Biologix, a leader in the regenerative medicine industry, has announced the addition of Sean Woodward as the new Marketing Manager to their Salt Lake City based team, effective immediately

APEX Biologix expands its XCELL product line to include a bone marrow concentration

APEX Biologix expands its XCELL product line to include a bone marrow concentration

Salt Lake City, Utah, May 23, 2019 – APEX Biologix is proud to introduce an exciting new bone marrow concentration device designed to maximize mesenchymal total nucleated cell (MSC) numbers from bone marrow aspirate.

APEX Biologix: The release of its new Class II FDA approved XCELL PRP system.

APEX Biologix: The release of its new Class II FDA approved XCELL PRP system.

Salt Lake City, Utah, April 8, 2019 – Today, APEX Biologix formally announced the launch of their next generation and newly refined platelet rich plasma system under the 510 K number BK180252. 

Due to the overwhelming demand and popularity of the XCELL PRP system, APEX Biologix

Due to the overwhelming demand and popularity of the XCELL PRP system, APEX Biologix

Salt Lake City, Utah, September 25, 2018 – APEX Biologix would like to formally thank all their clients in making the launch of their XCELL PRP system so successful. 

APEX Biologix announces their new XCELL PRP system

APEX Biologix announces their new XCELL PRP system

Salt Lake City, Utah, July 10, 2018 – APEX Biologix formally announced today the launch of their new platelet rich plasma system. 

APEX Biologix, LLC Partnership with Physicians Success RX, LLC

APEX Biologix, LLC Partnership with Physicians Success RX, LLC

Salt Lake City, Utah, December 1, 2017 – Representatives from APEX Biologix, LLC are pleased to announce their new partnership with the medical business experts at Physicians Success RX. 

Image

An industry leader, we are dedicated to the science and research of regenerative medicine and its potential by supplying physicians with the best products on the market to treat their patients.

Privacy Policy

Contact Us